期刊文献+

无刺激周期未成熟卵母细胞体外培养用于多囊卵巢综合征不孕患者治疗的临床观察 被引量:22

In vitro maturation and fertilization of oocytes from unstimulated cycles in women with infertility due to polycystic ovary syndrome
原文传递
导出
摘要 目的探讨无刺激周期未成熟卵母细胞体外培养在治疗多囊卵巢综合征(PCOS)不孕患者的应用价值。方法对70例PCOS患者,在人工周期或自然周期第10~12天行阴道B超监测,如双侧卵巢中无直径>8mm的卵泡,即肌内注射人绒毛膜促性腺激素10000IU,36h后经阴道穿刺取卵,将取出的未成熟卵母细胞进行体外成熟及体外受精胚胎移植。结果共进行体外成熟周期94个,移植周期75个。共获得卵母细胞1283个,获得成熟838个(65.3%,838/1283),其中受精553个(66.0%,553/838),获得胚胎402个(48.0%,402/838),获得优质胚胎199个(23.7%,199/838)。生发泡期卵母细胞的成熟率、受精率、获得胚胎率及优质胚胎率,分别为67.7%、66.4%、47.6%及24.1%;第1次减数分裂中期的卵母细胞,分别为69.7%、71.7%、52.2%及26.1%,生发泡期与第1次减数分裂中期比较,差异均无统计学意义(P>0.05)。无法评价的卵母细胞的成熟率、受精率、获得胚胎率及优质胚胎率,分别为44.8%、53.8%、46.2%及16.9%,与生发泡期及第1次减数分裂中期比较,差异均有统计学意义(P<0.05)。75个移植周期中,18例获得临床妊娠,妊娠率为24%(18/75)。结论无刺激周期未成熟卵母细胞体外成熟及体外受精胚胎移植可用于PCOS不孕患者的治疗,并能取得一定的妊娠成功率。 Objective To investigate the effect of in vitro maturation(IVM) and fertilization of oocytes from unstimulated cycles in women with infertility due to polycystic ovary syndrome(PCOS). Methods Seventy women with PCOS, who came to our clinic during March to were involved in this trial. June 2003. Every cycle was given human chorionic gonadotropin 10 000 IU 36 h before oocyte retrieval. Immature oocytes were matured in vitro and fertilized, and the resulting embryos were replaced back to the uterus. Results A total of 94 IVM cycles were performed and 1283 oocytes were obtained. The overall maturation, fertilization and cleavage rates were 65.3%, 66.0% and 48.0% respectively. Maturation, fertilization, cleavage and high quality embryo rates had no difference between metaphase I stage oocytes (69.7%, 71.7%, 52.2% and 26.1% respectively) and germinal vesical (GV) stage oocytes (67.7%, 66.4%, 47.6% and 24.1% respectively), but the rates in those oocytes which could not be classified (44.8%, 53.8%, 46.2% and 16.9% respectively) were much lower than the former two groups. After embryo transfer, 18 pregnancies were reported (24%). Conclusion IVM/IVF-ET in unstimulated cycles is a feasible treatment for women with PCOS.
出处 《中华妇产科杂志》 CAS CSCD 北大核心 2005年第6期388-391,共4页 Chinese Journal of Obstetrics and Gynecology
  • 相关文献

参考文献16

  • 1Cha KY,Han SY,Chung HM,et al.Pregnancies and deliveries after in vitro maturation culture followed by in vitro fertilization and embryo transfer without stimulation in women with polycystic ovary syndrome.Fertil Steril,2000,73:978-983.
  • 2Balen A.Polycystic ovary syndrome: mode of treatment.In: Shoham Z,Howles CM,Jacobs HS,eds.Female infertility therapy.London: Martin Dunitz,1999.45-69.
  • 3Chian RC,Buckett WM,Tulandi T,et al.Prospective randomized study of human chorionic gonadotrophin priming before immature oocyte retrienval from unstimulated women with polycystic ovarian syndrome.Hum Reprod,2000,15:165-170.
  • 4Mikkelson AL,Smith S,Lindenberg S.Impact of oestradiol and inhibin A concentrations on pregnancy rate in in-vitro oocyte maturation.Hum Reprod,2000,15:1685-1690.
  • 5Rubio Pomar FJ,Roelen BA,Slot KA,et al.Role of Fas-mediated apoptosis and follicle-stimulating hormone on the developmental capacity of bovine cumulus oocyte complexes in vitro.Biol Reprod,2004,71:790-796.
  • 6Sutton-McDowall ML,Gilchrist RB,Thompson JG.Cumulus expansion and glucose utilisation by bovine cumulus-oocyte complexes during in vitro maturation: the influence of glucosamine and follicle-stimulating hormone.Reproduction,2004,128:313-319.
  • 7Suikkari AM,Tulppala M,Tuuri T,et al.Luteal phase start of low-dose FSH priming of follicles results in an efficient recovery,maturation and fertilization of immature human oocytes.Hum Reprod,2000,15: 747-751.
  • 8Wynn P,Picton HM,Krapez JA,et al.Pretreatment with follicle stimulating hormone promotes the numbers of human oocytes reaching metaphase II by in-vitro maturation.Hum Reprod,1998,13: 3132-3138.
  • 9Mikkelsen AL,Lindenberg S.Benefit of FSH priming of women with PCOS to the in-vitro maturation procedure and the outcome: a randomized prospective study.Reproduction,2001,122:587-592.
  • 10Lin YH,Hwang JL,Huang LW,et al.Combination of FSH priming nad hCG priming for in-vitro maturation of human oocytes.Hum Reprod,2003,18:1632-1636.

二级参考文献9

  • 1Trounson A, Wood C, Kausche A. In vitro maturation and the fertilization and developmental competence of oocytes recovered from untreated polyeystie ovarian patients[J]. Fertil Steril, 1994, 62( 2 ) :353-362.
  • 2Einspanier R, Schonfelder M, Muller K, et al. Exptessian of the vascular endothehal growth factor and its receptors and effects of VEGF during in vitro maturation of bovine cumulus-oocyte complex(COC)[J]. Mol Reprod Dev, 2002, 62( 1 ) :29-36.
  • 3Sakaguchi M, Dominko T, Yamauchi N, et al. Possible mechanism for acceleration of meiotic progression of bovine follicular oocytes by growth factors in vitro [ J ]. Reproduction, 2002, 123 ( 1 ) : 135-142.
  • 4Pang Y, Ge W. Epidermal growth factor and TGFalpha promote zebrafish oocyte maturation in vitro: potential role of the ovarian activin regulatory system[ J ]. Endocrinology, 2002, 143 (1) :47-54.
  • 5Guler A, Poulin N, Mermillod P, et al. Effect of growth factors,EGF and IGF-I, and estradiol on in vitro maturation of sheep oocytes [ J ]. Theriogenology, 2000, 54 ( 2 ) : 209-218.
  • 6Reeka N, Berg FD, Brucker C. Presence of transforming growth factor alpha and epidermal growth factor in human ovarian tissue and follicular fluid[J]. Hum Reprod, 1998, 13(8) :2199-2205.
  • 7Abdoon AS, Kandil OM, Otoi T, et al. Influence of oocyte quality, culture media and gonadotropins on cleavage rate and development of in vitro fertilized buffalo embryos[ J ]. Anim Reprod Sci, 2001, 65(3-4):215-223.
  • 8Chian RC, Ao A, Clarke H J, et al. Production of steroids from human cumulus cells treated with different concentrations of gonadotropins during culture in vitro[J]. Fertil Steril, 1999, 71(1) :61-66.
  • 9Liu HC, He Z, Rosenwarks Z. In vitro culture and in vitro maturation of mouse preantral follicles with recombinant gonadotropins[J]. Fertil Steril, 2002, 77(2):373-383.

共引文献11

同被引文献270

引证文献22

二级引证文献147

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部